Labopharm once-daily painkiller to receive U.S. review; Euro partner signed

LAVAL, Que. (CP) - Labopharm Inc. (TSX:DDS) said Monday its new drug application for a once-daily formulation of the painkiller tramadol has been accepted for review and filed by the U.S. Food and Drug Administration....More